Sugi Predict

Sugi Predict / Compounds / SCHEMBL1664553

SCHEMBL1664553

SCHEMBL1664553

CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 3/20 0.66
▸ ALDH1A1 P00352 6/20 0.56
▸ HPGD P15428 1/20 0.56
▸ CYP19A1 P11511 2/20 0.55
▸ TRPM8 Q7Z2W7 3/20 0.50
▸ TRPA1 O75762 2/20 0.50
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ TSHR P16473 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ P2RX4 Q99571 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1075939 1.00 EPHX1 (0.66) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL15797823 1.00 EPHX1 (0.66) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL5125211 1.00 EPHX1 (0.66) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL3127776 0.96 EPHX1 (0.62) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL14355425 0.96 EPHX1 (0.62) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL17407566 0.96 EPHX1 (0.62) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL14616021 0.96 EPHX1 (0.62) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL6129364 0.96 EPHX1 (0.62) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL15391216 0.91 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1TRPM8
SCHEMBL24470289 0.91 EPHX1 (0.60) EPHX1ALDH1A1HPGDCYP19A1TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119015152-A Composition containing menthol carbonate precursor compound and use thereof 重庆医科大学 2024-11-26 — — CN claimed
CN-118812470-A Menthol carbonate precursor compound and synthesis method thereof 重庆医科大学 2024-10-22 — — CN claimed
CN-114516797-B Methyl cyclopentenolone menthol carbonate spice and synthetic method and application thereof 安徽中烟工业有限责任公司 2023-09-08 — — CN claimed
CN-114516797-A Methyl cyclopentenolone menthol carbonate spice as well as synthesis method and application thereof 安徽中烟工业有限责任公司 2022-05-20 — — CN claimed
CN-113979864-A One-pot synthesis method of novel menthol carbonate cooling agent and application of novel menthol carbonate cooling agent in cigarettes 云南中烟工业有限责任公司 2022-01-28 — — CN claimed
CN-111517957-B Perilla alcohol and menthol carbonate spice 北京工商大学 2022-01-25 — — CN claimed
EP-2903979-B1 NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES INHIBIKASE THERAPEUTICS INC (US) 2020-08-19 — — EP claimed
CN-108360256-B Liquid temporary solid material and preparation method and application thereof 上海大学 2020-04-14 — — CN claimed
US-9907796-B2 Methods of treating tumoral diseases, or bacterial or viral infections INHIBIKASE THERAPEUTICS, INC. (US) 2018-03-06 — — US claimed
US-20170000789-A1 Methods of Treating Tumoral Diseases, or Bacterial or Viral Infections SPHAERA PHARMA PTE. LTD. (SG) 2017-01-05 — — US claimed
US-9487500-B2 Compounds and compositions thereof INHIBIKASE THERAPEUTICS, INC. (US) 2016-11-08 — — US claimed
US-9359376-B2 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds SPHAERA PHARMA PTE. LTD (SG) 2016-06-07 — — US claimed
US-20140121367-A1 SUBSTITUTED METHYLFORMYL REAGENTS AND METHOD OF USING SAME TO MODIFY PHYSICOCHEMICAL AND/OR PHARMACOKINETIC PROPERTIES OF COMPOUNDS PIVOT HOLDING LLC 2014-05-01 — — US claimed
CN-118812470-B Menthol carbonate precursor compound and synthesis method thereof 重庆医科大学 2025-09-05 — — CN disclosed
CN-119015152-A Composition containing menthol carbonate precursor compound and use thereof 重庆医科大学 2024-11-26 — — CN disclosed
CN-119015152-A Composition containing menthol carbonate precursor compound and use thereof 重庆医科大学 2024-11-26 — — CN disclosed
CN-1487829-A Chewing gums and related products that provide breath freshening characteristics WM���׸���JR����˾ 2004-04-07 — — CN disclosed
US-6506368-B2 Encapsulating a mixture of a lipophilic core material and an oil-soluble dye, wherein said dye is D&C Green No. 6 or guaizulene or mixture of two dyes HAARMANN & REIMBER GMBH (DE) 2003-01-14 — — US disclosed
US-20020159957-A1 Process for producing blue microcapsules SYMRISE AG (DE) 2002-10-31 — — US disclosed
US-6359168-B1 ORGANOLEPTIC FIRMENICH SA (CH) 2002-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140121367-A1 SUBSTITUTED METHYLFORMYL REAGENTS AND METHOD OF USING SAME TO MODIFY PHYSICOCHEMICAL AND/OR PHARMACOKINETIC PROPERTIES OF COMPOUNDS TPMT, BHMT2, PFAS EPHX1 808/4885ALDH1A1 524/4885HPGD 1888/4885
US-20170000789-A1 Methods of Treating Tumoral Diseases, or Bacterial or Viral Infections POLI, RNASE1, VHL EPHX1 2104/4885ALDH1A1 1777/4885HPGD 1008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.